CIK 0001674632 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company
Beta Bionics, Inc.
Sign in to watch- Ticker
- BBNX
- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 475386878
- Phone
- 949-427-7785
- Business address
- 11 HUGHES, IRVINE, CA, 92618
- Former names
- Beta Bionics, Inc
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $3,285,734
- in 20 filings, $2.5M under 10b5-1 plans
Net −$3,285,734. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-01-31 | Mensinger Mike Chief Product Officer | Conversion | +15,107 | 15,107 | ||
| 2025-01-31 | Mensinger Mike Chief Product Officer | Option exercise | +10,575 | $0.02 | $212 | 25,682 |
| 2025-01-31 | Mensinger Mike Chief Product Officer | Sale | −13 | $17.00 | $221 | 25,669 |
| 2025-01-31 | Mensinger Mike Chief Product Officer | Purchase | +33,350 | $17.00 | $567K | 59,019 |
| 2025-01-31 | Mensinger Mike Chief Product Officer | Conversion · Series D Preferred Stock | −15,107 | 0 | ||
| 2025-01-31 | Mensinger Mike Chief Product Officer | Conversion · Class B Common Stock Warrant (right to buy) | +10,575 | 10,575 | ||
| 2025-01-31 | Mensinger Mike Chief Product Officer | Option exercise · Class B Common Stock Warrant (right to buy) | −10,575 | 0 | ||
| 2025-01-31 | Mensinger Mike Chief Product Officer | Grant or award · Employee Stock Option (right to buy) | +236,553 | 236,553 | ||
| 2025-01-31 | Mensinger Mike Chief Product Officer | Grant or award · Employee Stock Option (right to buy) | +110,278 | 110,278 | ||
| 2025-01-31 | Jones Christy Director | Grant or award · Director Stock Option (right to buy) | +9,137 | 9,137 | ||
| 2025-01-31 | Jones Christy Director | Grant or award · Director Stock Option (right to buy) | +9,137 | 9,137 | ||
| 2025-01-31 | Jones Christy Director | Grant or award · Director Stock Option (right to buy) | +48,730 | 48,730 | ||
| 2025-01-31 | Hopman Mark Chief Commercial Officer | Grant or award · Employee Stock Option (right to buy) | +83,242 | 83,242 | ||
| 2025-01-31 | Hopman Mark Chief Commercial Officer | Grant or award · Employee Stock Option (right to buy) | +37,229 | 37,229 | ||
| 2025-01-31 | Hopman Mark Chief Commercial Officer | Grant or award · Employee Stock Option (right to buy) | +17,765 | 17,765 | ||
| 2025-01-31 | Hopman Mark Chief Commercial Officer | Grant or award · Employee Stock Option (right to buy) | +39,424 | 39,424 | ||
| 2025-01-31 | Hopman Mark Chief Commercial Officer | Grant or award · Employee Stock Option (right to buy) | +47,775 | 47,775 | ||
| 2025-01-31 | Feider Stephen Chief Financial Officer | Grant or award · Employee Stock Option (right to buy) | +166,542 | 166,542 | ||
| 2025-01-31 | Feider Stephen Chief Financial Officer | Grant or award · Employee Stock Option (right to buy) | +109,695 | 109,695 | ||
| 2025-01-31 | Feider Stephen Chief Financial Officer | Grant or award · Employee Stock Option (right to buy) | +186,203 | 186,203 |
Page 10 of 11 · 210 trades